Ototoxicity from Combined Cisplatin and Radiation Treatment: An In Vitro Study

@inproceedings{Low2010OtotoxicityFC,
  title={Ototoxicity from Combined Cisplatin and Radiation Treatment: An In
Vitro Study},
  author={Wong Kein Low and Sylvia W. W. Kong and Michelle Guet Khim Tan},
  booktitle={International journal of otolaryngology},
  year={2010}
}
Objective. Combined cisplatin (CDDP) and radiotherapy is increasingly being used to treat advanced head and neck cancers. As both CDDP and radiation can cause hearing loss, it is important to have a better understanding of the cellular and molecular ototoxic mechanisms involved in combined therapy. Procedure. The effects of CDDP, radiation, and combined CDDP-radiation on the OC-k3 cochlear cell line were studied using MTS assay, flow cytometry, Western blotting, and microarray analysis. Results… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2006
View 3 Excerpts

Mechanisms of hair cell death and protection.

Current opinion in otolaryngology & head and neck surgery • 2005
View 2 Excerpts

Similar Papers

Loading similar papers…